February 28, 2015 3:30 PM ET


Company Overview of Nucleonics, Inc.

Executive Profile

Robert J. Towarnicki

Chief Executive Officer and President, Makefield Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships


Mr. Robert J. Towarnicki serves as Chief Executive Officer and President of Makefield Therapeutics Inc. Mr.Towarnicki has over 30 years experience in the pharmaceutical and biotechnology industry. He served as President of three biotech companies and has raised over $200 Million USD for those companies to further the development of novel technologies including small molecule pharmaceuticals, PMA and 510k medical devices and diagnostic assays. He has extensive experience ...

Corporate Headquarters

13 Summit Square Center
Langhorne, Pennsylvania 19047-1098

United States

Phone: 267-518-0100
Fax: 267-518-0054

Board Members Memberships

Chief Executive Officer, President and Director
Former Chairman of the Board, Chief Executive Officer and President


Villanova University
BS 1973
Villanova University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nucleonics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.